Human cell lines, derived from AHH-1 TK+/- human lymphoblasts, genetically engineered for expression of cytochromes P450.
暂无分享,去创建一个
[1] F. Gonzalez,et al. A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing. , 1991, Chemical research in toxicology.
[2] A. Natarajan,et al. Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens. , 1991, Mutagenesis.
[3] F. Gonzalez,et al. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. , 1991, Carcinogenesis.
[4] H. Ramsdell,et al. Bioactivation of aflatoxin B1 by human liver microsomes: role of cytochrome P450 IIIA enzymes. , 1991, Toxicology and applied pharmacology.
[5] J. A. Bond,et al. Particle-associated polycyclic aromatic hydrocarbons--a reappraisal of their possible role in pulmonary carcinogenesis. , 1991, Toxicology and applied pharmacology.
[6] F. Guengerich,et al. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. , 1991, Chemical research in toxicology.
[7] F. Gonzalez,et al. The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3. , 1991, Carcinogenesis.
[8] M. P. Arlotto,et al. Human cytochrome P450IIA3: cDNA sequence role of the enzyme in the metabolic of promutagens comparison to nitrosamine activation by human cytochrome P450IIE1 , 1990 .
[9] F. Gonzalez,et al. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. , 1990, Biochemistry.
[10] H. Ramsdell,et al. Comparative Kinetics of Microsomal Biotransformation Species Susceptibility to Aflatoxin B1 Carcinogenesis , 1990 .
[11] L. Marnett,et al. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. , 1989, Cancer research.
[12] T. Aoyama,et al. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. , 1989, The Journal of biological chemistry.
[13] T. Shimada,et al. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. , 1989, Cancer research.
[14] R. Langenbach,et al. Development of a human cell line by selection and drug-metabolizing gene transfection with increased capacity to activate promutagens. , 1989, Carcinogenesis.
[15] Yao-Tseng Chen,et al. Transfection of a human cytochrome P-450 gene into the human lymphoblastoid cell line, AHH-1, and use of the recombinant cell line in gene mutation assays. , 1989, Carcinogenesis.
[16] F. Gonzalez,et al. The molecular biology of cytochrome P450s. , 1988, Pharmacological reviews.
[17] T. Kronbach,et al. High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. , 1987, Analytical biochemistry.
[18] B. W. Penman,et al. Mutagenicity of 1,2-dichloroethane and 1,2-dibromoethane in two human lymphoblastoid cell lines. , 1985, Mutation research.
[19] J. Yates,et al. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus , 1985, Molecular and cellular biology.
[20] W. Thilly,et al. Assay for gene mutation in a human lymphoblast line, AHH-1, competent for xenobiotic metabolism. , 1984, Mutation research.
[21] O. Hankinson,et al. Single-step phototoxic selection procedure for isolating cells that possess aryl hydrocarbon hydroxylase. , 1983, Cancer research.
[22] J. Minowada,et al. Induction, inhibition, and biological properties of aryl hydrocarbon hydroxylase in a stable human B-lymphocyte cell line, RPMI-1788. , 1979, Cancer research.
[23] B. Paigen,et al. Aryl hydrocarbon hydroxylase in a stable human B-lymphocyte cell line, RPMI-1788, cultured in the absence of mitogen. , 1979, Cancer research.
[24] J. Smyth,et al. Progress in Clinical and Biological Research , 1979 .
[25] B. Ames,et al. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[26] H. Malling. Dimethylnitrosamine: formation of mutagenic compounds by interaction with mouse liver microsomes. , 1971, Mutation research.
[27] C. Crespi. Expression of cytochrome P450 cDNAs in human B lymphoblastoid cells: applications to toxicology and metabolite analysis. , 1991, Methods in enzymology.
[28] F. Gonzalez,et al. Stable expression of human cytochrome P450IA2 cDNA in a human lymphoblastoid cell line: Role of the enzyme in the metabolic activation of aflatoxin B1 , 1990, Molecular carcinogenesis.
[29] R. Langenbach,et al. The development of a panel of human cell lines expressing specific human cytochrome P450 cDNAs. , 1990, Progress in clinical and biological research.
[30] B. W. Penman,et al. Sodium fluoride is a less efficient human cell mutagen at low concentrations , 1990, Environmental and molecular mutagenesis.
[31] B. W. Penman,et al. The induction of aneuploidy by nitrogen mustard in a human lymphoblastoid cell line. , 1987, Mutation research.
[32] M. Marletta,et al. Xenobiotic metabolism and mutation in a human lymphoblastoid cell line. , 1985, Chemico-biological interactions.
[33] E. Furth,et al. Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. , 1981, Analytical biochemistry.
[34] S. Colowick,et al. Methods in Enzymology , Vol , 1966 .